NTLA vs VNQ
Intellia Therapeutics Inc (NTLA) versus VNQ (VNQ) — a side-by-side from cached financials, not a winner call.
Intellia Therapeutics Inc (NTLA) is a biotechnology company listed on US.
VNQ (VNQ) common stock.
Latest reported NTLA revenue for 2026-06-30 was $22.7M. Net income was -$202.9M. Revenue was up 50.9% from 2026-03-31 to 2026-06-30. NTLA currently screens at market cap $1.19B.
VNQ does not have a complete income-statement cache yet.
NTLA currently screens at market cap $1.19B. VNQ currently screens at market cap $0.
Not investment advice. Open the NTLA and VNQ stock pages for the full models.
Not investment advice.